Reporting patterns of adverse drug reactions over recent years in China: Analysis from publications

Expert Opinion on Drug Safety

Volumn 14, Issue 2, 2015, Pages 191-198

  Guo, Xiao Jing ^a   Ye, Xiao Fei ^a   Wang, Xing Xing ^b   Wang, Jing ^a   Shi, Wen Tao ^a   Gao, Qing Bin ^a   Zhang, Tian Yi ^a   Xu, Jin Fang ^a   Zhu, Tian Tian ^a   He, Jia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

China; Pharmacovigilance; Reporting pattern; Self reported adverse drug reaction

Indexed keywords

ANTIINFECTIVE AGENT; HERBACEOUS AGENT;

ARTICLE; CHINA; CHINESE MEDICINE; DRUG SURVEILLANCE PROGRAM; FEVER; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PERSONNEL; HEART PALPITATION; HUMAN; LIVER INJURY; PRURITUS; PUBLICATION; RASH; SELF REPORT; UNSPECIFIED SIDE EFFECT; ADVERSE EFFECTS; AGE DISTRIBUTION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; TRENDS;

AGE DISTRIBUTION; ANTI-INFECTIVE AGENTS; CHINA; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; MEDICINE, CHINESE TRADITIONAL; PERIODICALS AS TOPIC; SELF REPORT;

EID: 84921367651     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2015.985647     Document Type: Article

References (38)

1. WHO Collaborating Centre for International Drug Monitoring. The importance of pharmacovigilance. World Health Organization, Geneva; 2002
2. Aagaard L, Strandell J, Melskens L, et al. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase. Drug Saf 2012;35(12):1171-82
3. Sharma M, Gupta S. Postmarketing surveillance. In: Gupta SK, editor. Textbook of pharmacovigilance. Jaypee Brothers; New Delhi: 2011
4. Uppsala Monitoring Centre. VigiBase reaches 9 million reports. 2014. www.who-umc.org/DynPage.aspx?id=105196&mn1=7347&mn2=7489&mn3=7248&newsid=11561 [Accessed 23 June 2014]
5. Olsson S, Pal SN, Stergachis A, et al. Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis. Drug Saf 2010;33(8):689-703
6. Zhang L, Wong LY, He Y, et al. Pharmacovigilance in china: current situation, successes and challenges. Drug Saf 2014;37(10):765-70
7. China Food and Drug Administration. CFDA releases 2013 Annual Report for National Adverse Drug Reaction Monitoring. 2014. Available from: www.sda.gov.cn/WS01/CL0078/99794.html [Accessed 14 May 2014]
8. China Food and Drug Administration. 2014.Available from: www.sda.gov.cn/WS01/CL0001/ [Accessed 6 June 2014]
9. National Center for ADR Monitoring, China. Available from: www.cdr.gov.cn/ [Accessed September 2014]
10. China Food and Drug Administration. SFDA releases 2009 Annual Report for National Adverse Drug Reaction Monitoring. 2010. Available from: www.sda.gov.cn/WS01/CL0051/48201.html [Accessed 6 March 2013]
11. China Food and Drug Administration. SFDA releases 2010 Annual Report for National Adverse Drug Reaction Monitoring. 2011. Available from: www.sda.gov.cn/WS01/CL0051/60952.html [Accessed 6 March 2013]
12. China Food and Drug Administration. SFDA releases 2011 Annual Report for National Adverse Drug Reaction Monitoring. 2012. Available from: www.sda.gov.cn/WS01/CL0051/72190.html [Accessed 6 March 2013]
13. China Food and Drug Administration. SFDA releases 2012 Annual Report for National Adverse Drug Reaction Monitoring. 2013. Available from: http://app1.sfda.gov.cn/WS01/CL0051/79058.html [Accessed 15 March 2013]
14. Wang D, Cheng G. Annual trend analysis of adverse drug reaction data. Chin J Pharmacoepidemiol 22(5):238-41
15. MHRA. Drug Alerts. 2014. Available from: www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/index.htm [Accessed 6 September 2014]
16. FDA. Reports Received and Reports Entered into FAERS by Year. 2014. Available from: www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm070434.htm [Accessed 5 September 2014]
17. FDA. FDA Adverse Event Reporting System (FAERS). 2014. Available from: www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm [Accessed 6 September 2014]
18. Uppsala Monitoring Centre. Uppsala Reports 63. In: Centre UM, editor. Uppsala Monitoring Centre; Sweden: 2013. 7
19. MHRA MHRA annual statistics 2010/11
20. MHRA Credit card sized information card on Yellow Card reporting for healthcare professionals. 2010. Available from: https://yellowcard.mhra.gov.uk/-assets/files/Healthcare-Professional-Information-Card.pdf [Accessed 6 September 2014]
21. Health Canada. Adverse reaction and incident reporting-2011. Can Adverse React Newsl 2012;22(3):3-6
22. Aagaard L, Nielsen LH, Hansen EH. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Saf 32 (11):1067-74
23. Fortnum H, Lee AJ, Rupnik B, et al. Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain. J Clin Pharm Ther 37(2):161-5
24. Tang JL, Liu BY, Ma KW. Traditional Chinese medicine. Lancet 2008;372(9654):1938-40
25. Zhang L, Yan J, Liu X, et al. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective. J Ethnopharmacol 2012;140(3):519-25
26. Wang H, Ye X, Gao Q, et al. Pharmacovigilance in Traditional Chinese Medicine safety surveillance. Pharmacoepidemiol Drug Saf 2009;18(5):357-61
27. BI F, zhang L. Discussion on the Safety of Traditional Chinese Medicine Injection. Chin J Pharmacol 2012;9(2):89-92
28. Becker ML, Visser LE, van Gelder T, et al. Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged > or = 55 years. Drugs Aging 25(2):145-52
29. Tulner LR, Frankfort SV, Gijsen GJ, et al. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 25(4):343-55
30. Obreli-Neto PR, Nobili A, de Oliveira Baldoni A, et al. Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. Eur J Clin Pharmacol 2012;68(12):1667-76
31. Wu C, Bell CM, Wodchis WP. Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study. Drug Saf 2012;35(9):769-81
32. Bian ZX, Tian HY, Gao L, et al. Improving reporting of adverse events and adverse drug reactions following injections of Chinese materia medica. J Evid Based Med 3(1):5-10
33. Bate A, Evans SJ. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf 2009;18(6):427-36
34. Copas JB, Hilton FJ. Record linkage: statistical models for matching computer records. J R Stat Soc Ser A Stat Soc 1990;153(3):287-320
35. Roland GN, Andrew B. A Hit-Miss Model for Duplicate Detection in the WHO Drug Safety Database. Proceedings of the eleventh ACM SIGKDD international conference on Knowledge discovery in data mining; Chicago, Illinois USA; 2005. p. 459-68
36. WHO. A practical handbook on the pharmacovigilance of antimalarial medicines. WHO; Geneva: 2008
37. WHO. A practical handbook on the pharmacovigilance of antiretroviral medicines. WHO; Geneva: 2009
38. WHO. A practical handbook on the pharmacovigilance of medicines used in the treatment of tuberculosis. WHO; Geneva: 2012